|Articles|January 18, 2002
CDER Drug Information, Updated 12/27/01
Author(s)BioPharm International Editors
New and Generic Drug Approvals [Includes Drug Label and Approval Letter] (Updated 12/27/2001)
Advertisement
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
2
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
5